alpidem has been researched along with Interstitial Cell Tumor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altomare, CD; Cutrignelli, A; Denora, N; Franco, M; Laquintana, V; Lopedota, A; Midzak, A; Papadopoulos, V | 1 |
1 other study(ies) available for alpidem and Interstitial Cell Tumor
Article | Year |
---|---|
2-Phenylimidazo[1,2-a]pyridine-containing ligands of the 18-kDa translocator protein (TSPO) behave as agonists and antagonists of steroidogenesis in a mouse leydig tumor cell line.
Topics: Animals; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Dose-Response Relationship, Drug; Hormone Antagonists; Hydrogen Bonding; Imidazoles; Leydig Cell Tumor; Ligands; Male; Mice; Molecular Structure; Neoplasms, Hormone-Dependent; Pyridines; Receptors, GABA; Steroid Synthesis Inhibitors; Structure-Activity Relationship; Testicular Neoplasms | 2015 |